45 Cobaltate(2-), bis[2-[2-[5-(aminosulfonyl)-2-(hydroxy-κO)phenyl]diazenyl-κN1]-3-(oxo-κO)-N-phenylbutanamidato(2-)]-, hydrogen (1:2) for Sale
Acid Yellow 151 on sale
-
CAS No.:
12715-61-6
Acid yellow NW
-
CAS No.:
12715-61-6
chemicals
FDA,ISO,CE
Cobaltate(2-),
-
CAS No.:
12715-61-6
-
Grade:
Industrial Grade or Medical grade
-
Content:
99%
-
Packaging:
25KG PER DRUM
2,3-Dimethylbutane,Nucleating agent,metal Sodium
FDA
Acid Yellow 4R
-
CAS No.:
12715-61-6
-
Grade:
Industrial Grade
-
Content:
99.0%
-
Packaging:
25kg/Drum
Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed Additive
ISO Certificate,REACH
Products You May Be Interested in
acid yellow 151
-
CAS No.:
12715-61-6
Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool,farnesyl acetone
Acid Yellow 4R
-
CAS No.:
12715-61-6
- If you want to buy Tirzepatide, then ECHEMI will offer you multi-options. ECHEMI emphasizes on verifying suppliers of Tirzepatide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Tirzepatide with 70000+ customers on ECHEMI and make orders now.
- Tirzepatide 2023788-19-2 from ECHEMI are quality guaranteed. Our business partners are with certification, quanlification and so on. Tirzepatide will reach global regulation and requirement of various regions. Customized services of Tirzepatide will provided to customers on ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Tirzepatide.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide
-
QIngdao Sigma Chemical Co.,Ltd
-
Dongguan Chenguang Technology Co., Ltd.
-
BrightGene Health Technology Co., Ltd
-
Synpeptide Co., Ltd
-
Maintain Biotech Co.Ltd
-
NANJING HANXIN PHARMACEUTICAL TECHNOLOGY
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
-
Deepharma Peptides/supplement
-
Xiamen Top Health Biochem Tech. Co.,Ltd
-
First Rays Co.,Ltd